Speaker: Craig H. Mallinckrodt, Eli Lilly
A structured framework for assessing sensitivity to missing data assumptions in longitudinal clinical trials
Co-authors: Q. Lin and M. Molenberghs;
Pharmaceutical Statistics, Volume 12, Issue 1, Pages 1–6, January/February 2013 Abstract | Paper+ | Slides
Speaker: Scott W. Andersen, Eli Lilly
On the practical application of mixed effects models for repeated measures to clinical trial data
Co-author: Brian A. Millen;
Pharmaceutical Statistics, Volume 12, Issue 1, Pages 7–16, January/February 2013 Abstract | Paper+ | Slides
+ Papers available to view throughout 2013.
For a flier advertising the event, please click here.
Joint PSI, EFSPI & ASA BIOP Webinar: Estimands
PSI, the European Federation of Statisticians in the Pharmaceutical Industry (EFSPI) and the Biopharmaceutical Section of the American Statistical Association (ASA) are jointly organising a webinar on Estimands in Practice. Speakers from regulatory authorities (FDA and EMA) and industry will present on their experience on this topic to date.
Discover your potential by working as a Covance Senior Principal / Principal Biostatistician. You'll enjoy a varied role working for different sponsors across several therapeutic areas, leading projects and mentoring junior members of the department.
Biometrics at AstraZeneca provides the data that influences decisions on how we roll back the frontiers of science to bring life-changing medicines to the world. We are at the heart of design, analytics and interpretation of AstraZeneca’s portfolio.